Pfizer (NYSE: PFE) reported Q2 EPS of $0.77, $0.09 better than the analyst estimate of $0.68. Revenue for the quarter came in at $15.03 billion versus the consensus estimate of $14.42 billion.

GUIDANCE:

Pfizer sees FY2026 EPS of $2.80-$3.00, versus the consensus of $2.95.

For earnings history and earnings-related data on Pfizer (PFE) click here.